365 related articles for article (PubMed ID: 15317702)
1. Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study.
Ciardella AP; Klancnik J; Schiff W; Barile G; Langton K; Chang S
Br J Ophthalmol; 2004 Sep; 88(9):1131-6. PubMed ID: 15317702
[TBL] [Abstract][Full Text] [Related]
2. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
Sutter FK; Simpson JM; Gillies MC
Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Avitabile T; Longo A; Reibaldi A
Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
[TBL] [Abstract][Full Text] [Related]
5. Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular oedema: a 6-month prospective pilot study.
Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Lai WW; Fan DS; Chan WM
Eye (Lond); 2005 Aug; 19(8):885-90. PubMed ID: 15389275
[TBL] [Abstract][Full Text] [Related]
6. Optical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedema.
Soliman W; Vinten M; Sander B; Soliman KA; Yehya S; Rahman MS; Larsen M
Acta Ophthalmol; 2008 Jun; 86(4):365-71. PubMed ID: 18028237
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.
Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Liu DT; Li KK; Li PS; Shanmugam MP
Ophthalmology; 2007 Dec; 114(12):2162-7. PubMed ID: 17459479
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
Chen SD; Sundaram V; Lochhead J; Patel CK
Am J Ophthalmol; 2006 May; 141(5):876-883. PubMed ID: 16527226
[TBL] [Abstract][Full Text] [Related]
9. Comparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema.
Lee HY; Lee SY; Park JS
Korean J Ophthalmol; 2009 Sep; 23(3):153-8. PubMed ID: 19794940
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal triamcinolone for diffuse diabetic macular oedema.
Gibran SK; Cullinane A; Jungkim S; Cleary PE
Eye (Lond); 2006 Jun; 20(6):720-4. PubMed ID: 16021193
[TBL] [Abstract][Full Text] [Related]
11. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
[TBL] [Abstract][Full Text] [Related]
12. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.
Batioğlu F; Ozmert E; Parmak N; Celik S
Int Ophthalmol; 2007 Oct; 27(5):299-306. PubMed ID: 17453151
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates.
Avci R; Kaderli B
Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):28-35. PubMed ID: 16034605
[TBL] [Abstract][Full Text] [Related]
14. The role of macular hydration in the evaluation of the effect of intravitreal triamcinolone on visual acuity in eyes with diabetic macular edema.
Sonmez K; Tezel TH; Kaplan HJ
Int Ophthalmol; 2013 Feb; 33(1):15-25. PubMed ID: 22890369
[TBL] [Abstract][Full Text] [Related]
15. The effects of intravitreal triamcinolone acetonide in diabetic macular edema refractory to anti-VEGF treatment.
Hong IH; Choi W; Han JR
Jpn J Ophthalmol; 2020 Mar; 64(2):196-202. PubMed ID: 31900869
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal triamcinolone as a primary therapy in diabetic macular oedema.
Karacorlu M; Ozdemir H; Karacorlu S; Alacali N; Mudun B; Burumcek E
Eye (Lond); 2005 Apr; 19(4):382-6. PubMed ID: 15309024
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomised trial of different doses of intravitreal triamcinolone for diabetic macular oedema.
Lam DS; Chan CK; Mohamed S; Lai TY; Li KK; Li PS; Tsang CW; Chan WM; Shanmugam MP
Br J Ophthalmol; 2007 Feb; 91(2):199-203. PubMed ID: 16973659
[TBL] [Abstract][Full Text] [Related]
18. The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal oedema and cataract.
Habib MS; Cannon PS; Steel DH
BMC Ophthalmol; 2005 Jun; 5():15. PubMed ID: 15972106
[TBL] [Abstract][Full Text] [Related]
19. Repeated intravitreal injection of triamcinolone for exudative age-related macular degeneration.
Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B
Ophthalmic Res; 2006; 38(6):324-8. PubMed ID: 17047404
[TBL] [Abstract][Full Text] [Related]
20. Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone.
Larsson J; Zhu M; Sutter F; Gillies MC
Am J Ophthalmol; 2005 May; 139(5):802-6. PubMed ID: 15860283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
